Use of Race and Ethnicity in Sickle Cell Disease Research
Aida Kidane(Erasmus MC - Sophia Children’s Hospital), Anita W. Rijneveld(Erasmus MC Cancer Institute), Amade M’charek(University of Amsterdam), Minke A.E. Rab(Utrecht University), Karlijn Meeks(University of Amsterdam)
Cited by 0
Related Papers
Rationale and cross-sectional study design of the Research on Obesity and type 2 Diabetes among African Migrants: the RODAM study
|BMJ Open|2014|123
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
|Blood|2024|88
AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes
|Haematologica|2020|81
Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients
|American Journal of Hematology|2019|76